Surfactant Deficiency Syndrome Neonatal
16
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 16 trials
100.0%
+13.5% vs benchmark
25%
4 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
deMISTify: The Impact of Ventilator Pressure Levels During Minimally Invasive Surfactant Therapy on Lung Aeration in Preterm Infants
Pragmatic Evaluation of Respiratory Distress Syndrome Treatment in Africa
Video vs. Direct Laryngoscopy for Less Invasive Surfactant Administration
Pain Assessment During Less-Invasive-Surfactant-Administration
Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes
Surfactant Administration by Insure or Thin Catheter
Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment
Fast Assessment of Surfactant Deficiency in Preterm Infants to Speed up Treatment - Validation Study
Surfactant Nebulization for the Early Aeration of the Preterm Lung
Less Invasive Surfactant Administration in Late Preterm or Early Term Born Infants
Premedication for Less Invasive Surfactant Administration
LISA vs INSURE in Extremely Low Birth Weight Infants. A Manikin Study
Study on the Effects of Different Premedication for LISA on Stress and Cerebral Tissue Oxygenation in Preterm Infants
Comparison of the Results of Transcutaneous Carbon Dioxide and Oxygen Pressure in Premature Neonates Who Underwent MIST Under HHHFNC or Nasal CPAP Methods
Feasibility Study - Neofact